Palantir has achieved massive revenue growth by delivering productivity gains for its customers.
Further long-term gains for investors may come down to how much of its valuation premium the stock can preserve.
Palantir (NASDAQ: PLTR) has become a phenomenally successful investment for longer-term shareholders, but also one that is difficult for new buyers to jump into. The stock is up about 25-fold from its December 2022 low. However, its elevated valuation also makes it risky to buy at current levels.
Long-term investors often buy stocks planning to hold them for a minimum of five years. Given that, it may be useful to speculate about where this stock could trade in 2031 and where that outcome would leave the value of a $5,000 investment made in it today. Although a lot could happen during that time that would dramatically alter any forecast we make this month, I think investors should prepare for significant struggles alongside the company's growth. Here's why.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Image source: The Motley Fool.
Trying to figure out what history says about Palantir can be challenging, though. From a certain perspective, the business can justify the stock's premium. The stock has been a tremendously successful investment because the company has delivered real productivity gains to its clients, particularly on the commercial side of its business.
One example is Citibank's CitiWealth, which used Palantir's software to streamline the onboarding process for new customers. This reduced the onboarding time for the most complex accounts from nine days to seconds. Now, a single employee can handle everything related to opening an account. Previously, 50 were involved in the process.
Also, the U.K.'s National Health Service is using Palantir's software to plan staffing, monitor patient demand, and track where hospital beds are available. This allows for more efficient resource allocation, reducing bottlenecks and shortening wait times.
Such productivity gains helped Palantir increase its revenue by 92% year over year in the first nine months of 2026. Due to a more modest rise in its costs and expenses, its profits during that time surged by 201% to almost $3.1 billion.
Though the AI data analytics company has been growing impressively, any forecast about what its growth might look like over the next five years will require a large dose of guesswork. The average forecast among analysts today is for an 84% revenue increase this year, then a deceleration to 51% growth in 2027. Grand View Research forecasts a 31% compound annual growth rate for the overall artificial intelligence industry through 2033. Since we do not have company-specific revenue forecasts for Palantir beyond 2027, that might be an appropriate estimate for its growth in the period ahead.
If we project a 52% rise in 2027 and a 31% increase each year thereafter, from projected revenue of $8.55 billion in 2026, the top line would rise to $38 billion by 2031.
However, investors have to remember that Palantir's current price-to-sales (P/S) ratio is 55. Considering that tech growth stocks often support P/S ratios in the teens or 20s, paying such a premium is likely risky in today's market.
Additionally, dividing Palantir's current $373 billion market cap by the projected $38 billion in revenue gives the stock a forward 2031 P/S ratio of 10. That sales multiple is on the lower end of what some tech growth stocks may command but remains significantly above the current S&P 500 average of 3.7.
Furthermore, investors tend to punish stocks for slowing growth, even when their prior growth rates were unsustainable. That is unlikely to bode well for Palantir stock over the next five years and, at least in the short and medium term, could put pressure on its stock price.
That said, Palantir deserves a valuation premium given its growth rate, and annualized revenue increases of 31% would arguably warrant that higher P/S ratio. Hence, investors should not expect that premium to completely disappear.
Amid the uncertainty, I expect that a $5,000 investment in the SaaS stock made today will be worth nearly the same five years from now.
Thanks to a massive premium in the stock price, investors who invest in Palantir today can expect the shares to face significant headwinds over the next five years. Most, if not all, of the revenue and earnings gains the company will make over that period have already been priced into the stock.
Admittedly, that is a somewhat conservative estimate. If the company's revenue growth does not decelerate to 31% as quickly as I anticipate, or if Palantir maintains a higher valuation premium, an investment in it could increase in value.
Nonetheless, investors should not expect the stock to maintain a 55 P/S ratio over time, particularly as its revenue growth slows. Although we can't know the extent of its future growth slowdown and multiple compression, such actions will likely pressure Palantir stock over the next five years.
Thus, even if that projection for the price of Palantir stock to stay essentially flat turns out to be conservative, investors should probably temper their expectations for its share price growth over the next five years.
Citigroup is an advertising partner of Motley Fool Money. Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy.